Maresin-2 nanotherapy disrupts inflammation-metabolism crosstalk via IL-6/JAK2/STAT3 axis modulation in obese colitis
Chemical Engineering Journal · 2026-12 · 550 · 184018
DOI: 10.1016/j.cej.2026.184018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-12. Verfasst von Yuchen Zhang und 12 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, Y., Liu, K., Wen, J., Wang, T., Zhou, H., Xue, Y., Zheng, X., Zheng, Y., He, J., Zhang, Y., Zhang, C., Tang, Y., & Wang, K. (2026). Maresin-2 nanotherapy disrupts inflammation-metabolism crosstalk via IL-6/JAK2/STAT3 axis modulation in obese colitis. Chemical Engineering Journal, 550, 184018. https://doi.org/10.1016/j.cej.2026.184018
Vancouver
Zhang Y, Liu K, Wen J, Wang T, Zhou H, Xue Y, et al. Maresin-2 nanotherapy disrupts inflammation-metabolism crosstalk via IL-6/JAK2/STAT3 axis modulation in obese colitis. Chemical Engineering Journal. 2026;550:184018. doi:10.1016/j.cej.2026.184018
BibTeX
@article{Zhang2026,
author = {Zhang, Yuchen and Liu, Kailai and Wen, Jinpeng and Wang, Ting and Zhou, Hanchao and Xue, Yanbo and Zheng, Xiaopu and Zheng, Yunhe and He, Jiangchuan and Zhang, Yue and Zhang, Chen and Tang, You and Wang, Ke},
title = {Maresin-2 nanotherapy disrupts inflammation-metabolism crosstalk via IL-6/JAK2/STAT3 axis modulation in obese colitis},
journal = {Chemical Engineering Journal},
year = {2026},
volume = {550},
pages = {184018},
doi = {10.1016/j.cej.2026.184018}
}
EUVIMED